Exact Sciences Corp at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. My name is Tejas Savant, and I work in the life sciences team here at JPMorgan. It's my pleasure this afternoon to introduce Kevin Conroy, CEO of Exact Sciences. After Kevin's presentation and after lunch at 1:30 p.m., there will be a breakout with the management team in the Olympic Room.
And with that, I'd like to hand it over to Kevin.
Last month, I attended the San Antonio Breast Cancer Symposium, which is the leading gathering of breast cancer oncologists and researchers in the world. And I left that meeting with a really important insight that we'll talk about later.
Thanks to Tejas, Tycho and JPMorgan, and welcome all of you and to those who are listening on the webcast.
We have a safe harbor statement. We will be making forward-looking statements.
Oncology is rapidly changing, and cancer diagnostics is fueling that change. At
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
